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Failure of immune reconstitution increases the risk of AIDS or non-AIDS related morbid-
ity and mortality in HIV-1-infected patients. CD3+CD4−CD8− T cells, which are usually 
described as double-negative (DN) T cells, display CD4-like helper and immunoregu-
latory functions. Here, we have measured the percentage of DN T cells in the immune 
reconstituted vs. non-immune reconstituted HIV-1-infected individuals. We observed that 
immunological non-responders (INRs) had a low number of DN T cells after long-term 
antiretroviral therapy (ART), and the number of these cells positively correlated with the 
CD4+ T cell count. The ART did not result in complete suppression of immune activation 
recorded by the percentage of CD38+HLA-DR+CD8+ T cells in INRs, and a strong inverse 
correlation was observed between DN T cells and immune activation. A low proportion of 
TGF-β1+DN T cells was found in INRs. Further mechanism study demonstrated that the 
level of TGF-β1-producing DN T cells and immune activation had a negative correlation 
after ART. Taken together, our study suggests that DN T cells control the immunological 
response in HIV-1-infected patients. These findings expand our understanding of the 
mechanism of immune reconstitution and could develop specific treatments to return the 
immune system to homeostasis following initiation of HIV-1 therapy.
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inTrODUcTiOn
CD3+CD4−CD8− double-negative (DN) T cells constitute approximately 1–5% of T lymphocytes 
in mice, non-human primates, and humans (1–4). These cells are also found in the lymph nodes, 
lungs, and gut-associated lymphoid tissues (5–8). They predominately have the memory phenotype 
(9), and it has been suggested that they play an important function in graft-vs.-host disease (10), 
autoimmune diseases (11), parasite infection (12), and infectious disease, such as HIV/SIV infection 
(5, 9, 13–15). DN T cells not only have a regulatory function similar to regulatory T cells (Tregs) but 
2Lu et al. DN T Cells in HIV-1
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 579
also secrete CD4-like cytokines (IL-4, IL-17, IFN-γ, and TNF-α) 
to exert their T helper function (4, 5, 12, 16, 17). In SIV-infected 
natural hosts, such as sooty mangabeys and African green mon-
keys, the frequency of DN T cells is about 10–40% of the total 
circulating lymphocytes (4). The maintenance of high numbers 
of these DN T cells capable of secreting T helper cytokines is 
associated with immune activation, and thus it is proposed that 
this can contribute to the prevention of SIV disease progression in 
natural host monkey species (4, 5, 9). In primary HIV-1-infected 
individuals, elevated DN T cells are associated with the control 
of immune activation and lower viral load (14). In addition to 
secreting IL-10 and TGF-β cytokine (14), DN T cells are also 
involved in restraining the CD8+ T cell immune activation dur-
ing primary HIV-1 infection (14). During the chronic phase, a 
decrease of DN T cells is correlated with rapid disease progression 
(13). Moreover, recently, DN T cells were identified as the latent 
HIV-1 reservoir that harbors HIV-1 Gag protein in the presence 
of antiretroviral therapy (ART) (18).
Nearly 20–30% of the HIV-1-infected patients lack the abil-
ity to fully recover CD4+ T cells after long-term ART (19, 20). 
These patients are considered as immunological non-responders 
(INRs). The failure of immune reconstitution eventually leads to 
the progression of AIDS or non-AIDS events, thereby increasing 
the morbidity and mortality in HIV/AIDS patients (21, 22). The 
underlying causes associated with INRs are age, low nadir CD4, 
high immune activation, and impaired thymus function (23–25).
The role of DN T cells in immune reconstitution has not been 
investigated. In the present study, the distribution of DN T cells 
and CD38+HLA-DR+CD8+ T cells as marker of immune activation 
was assessed in immunological responders (IRs) vs. INRs after 
prolonged ART in HIV-1 chronically infected patients. We found 
a higher number of DN T cells to be associated with a decreased 
number of CD38+HLA-DR+CD8+ T cells in IRs patients, suggest-
ing that DN T cells play a role in immune restoration. Moreover, 
the production of TGF-β1 by DN T cells might participate in the 
downregulation of immune activation after long-term ART.
MaTerials anD MeThODs
study subjects and ethical issues
Cryo-preserved peripheral blood mononuclear cells (PBMCs) 
were obtained from ART-treated chronic HIV-1-infected cohorts 
present in Beijing You’an Hospital. HIV-1 patients received ART 
for at least 1  year post-infection, and their CD4+ T cell count 
had dropped below 350  cells/μl. These patients were divided 
into two groups following a minimum of 2 years of ART: 17 IRs 
(CD4  >  500  cells/μl) and 19 immunological non-responders 
(INRs, CD4 < 350 cells/μl). Eighteen age-matched healthy con-
trols (HCs) were also included in this study. All the participants 
provided written informed consent. This study and all relevant 
experiments have been approved by the Beijing You’an Hospital 
Research Ethics Committee. The methods were carried out in 
accordance with the approved guidelines and regulations.
immunophenotyping
Cryo-preserved PBMCs were thawed in RPMI 1640 medium 
(Invitrogen, Carlsbad, CA, USA); then, these cells were washed 
with PBS containing 1% BSA. Briefly, cells were incubated at 
room temperature for 20 min with the cell viability marker fix-
able viability stain 510 (BD Biosciences, San Diego, CA, USA) 
and the following monoclonal conjugated antibodies: CD3-
PE-cy7 (SK7), CD4-APC-cy7 (SK3), CD8-PE (RPA-T8), CD8-
percp-cy5.5 (RPA-T8), HLA-DR-APC (TU36), and CD38-PE 
(HIT2) (BD Biosciences). Cells were washed and fixed with 2% 
paraformaldehyde, and at least 50,000 live lymphocytes were 
acquired with a BD FACSCanto II Flow Cytometry Analyzer 
Systems (BD Biosciences). Forward angle and side scatter light 
gating were used to exclude cell debris from the analysis. Forward 
width and forward area were used to exclude doublet cells. The 
final analysis was performed using the Flowjo7.6.1 software (Tree 
Star Inc., Ashland, OR, USA).
intracellular cytokine staining
Peripheral blood mononuclear cells (1 ×  106) were stimulated 
with PMA (500  ng/ml), ionomycin (2  μg/ml), and brefeldin 
A (10 μg/ml) for 5 h at 37°C in 5% CO2. The surface were stained 
with CD3-BV421 (UCHT1), CD8-percp-cy5.5 (RPA-T8), and 
CD4-FITC (RPA-T4) (BD Biosciences), and intracellular stain-
ing was performed using anti-IL-17A-PE (N49-653), IL-10-APC 
(JES3-19F1) (BD Biosciences), IL-4-APC (8D4-8), TGF-β1-PE 
(TW4-6H10), TNF-α-PE-cy7 (MAb11), and IFN-γ-PE-cy7 (4S.
B3) (Biolegend, San Diego, CA, USA) and the foxp3/transcrip-
tion factor staining buffer set (eBioscience, San Diego, CA, USA) 
according to the manufacturer’s protocols. Unstimulated cells 
were used as a negative control.
cD4+ T cell count and Viral load 
Measurement
Routine blood CD4+ T cell counts (cells per microliter) were 
measured by four-color flow cytometry using human CD45+, 
CD3+, CD4+, and CD8+ cell markers (BD Biosciences) in whole 
peripheral blood samples from each patient using FACS lysing 
solution (BD Biosciences) according to the manufacturer’s 
instructions. Plasma HIV-1 viral load (copies per milliliter of 
plasma) was quantified by real-time PCR (Abbort, Des Plaines, 
IL, USA). The sensitivity of viral RNA detection using this assay 
is 40 copies/ml of plasma.
statistical analysis
All statistical analyses were performed using the GraphPad Prism 
software v5.0 (GraphPad Software, Inc., La Jolla, CA, USA). The 
statistical significance between two groups was calculated using 
Mann–Whitney U test, and correlations were determined by 
the Spearman rank correlation test, with r being the Spearman 
correlation coefficient. The p < 0.05 was considered statistically 
significant.
resUlTs
characterization of the subjects
Thirty-six HIV-1-infected patients who had sustained undetect-
able viral load after treatment were divided into two groups: IRs 
(n = 17) and INRs (n = 19) according to their CD4+ T cell level 
Table 1 | characteristics of study subjects.
hiV-infected patients p Value
healthy controls  
(n = 18)
immunological responders  
(irs) (n = 17)
immunological non-responders  
(inrs) (n = 19)
ir vs. inr
Mean age (range) 38.13 (30–45) 38.76 (30–46) 37.12 (31–44) ns
Mean cD4% (range)
pre-ART 42 (21.9–67.2) 21.69 (9.51–53.9) 20.38 (6.4–40) 0.81
ART 31.07 (13.2–43.8) 31.08 (9.23–38.8) 0.47
Mean cD4 count (cells/μl) (range)
pre-ART 770.27 (484–1,238) 255.52 (183–336) 100 (88–292) 0.002
ART 718.7 (608–925) 272.15 (154–326) <0.0001
Mean viral load (log10, copies/ml) (range)
pre-ART NA 4.32 (3.14–5.74) 4.02 (1.97–5.07) ns
ART <40 <40 NA
Data are presented as mean (range).
p values were determined by Mann–Whitney U two-tailed t-test.
NA, not applicable; ns, not significant.
FigUre 1 | Double-negative (Dn) T cells are partially restored by prolonged antiretroviral therapy in immunological non-responders (inrs). 
(a) Representative flow cytometric plots of DN T cells from a healthy control (HC). Frequency (b) and count (c) of DN T cells were compared among three groups of 
study subjects (HC: n = 18, immunological responders: n = 17, and INR: n = 19). Mann–Whitney U test was used for statistical analysis. Horizontal lines indicate 
mean values, and error bars represent mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.0001).
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recorded after at least 2 years of treatment. Eighteen age-matched 
HCs were also part of this study (Table 1). These HIV-1-infected 
patients had no HBV or HCV co-infection. The plasma HIV-1 
viral load between IR and INR groups did not show any statisti-
cally significant difference before ART. The frequencies of CD4+ 
T cells also did not differ significantly in these two groups of 
patients, before or after ART, respectively. However, CD4+ T cell 
count in IR group patients was higher than in INR group patients 
(p = 0.002 before ART; p < 0.0001 after ART) and reached the 
level of HCs after ART administration.
long-term arT Only Partially restored 
the level of Dn T cells in the inr group of 
Patients
Double-negative T cells were defined as CD3+ T cells that lack 
CD4 and CD8 expression (Figure 1A). Consistent with previous 
published studies, chronic HIV-1 infection significantly reduced 
the count of DN T cells in comparison to HCs. Interestingly, ART 
was able to partially restore the number and percentage of DN 
T cells in all HIV-1-infected patients (Figure S1 in Supplementary 
FigUre 2 | correlation of double-negative (Dn) T cells with cD4+ T cell count. Correlation of the frequency (a) and count (b) of DN T cells with CD4+ T cell 
count, among HIV-1-infected patients before and after long-term antiretroviral therapy (ART). Correlation of the frequency (c) and count (D) of DN T cells with viral 
load among study subjects, before ART. The Spearman rank test was used for correlation analysis.
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Material). To further delineate the potential role of DN T cells in 
immune reconstitution, we analyzed their proportion and count 
according to their immune reconstitution status. As shown in 
Figures  1B,C, compared to HCs, the frequency of DN T cells 
in both IR and INR group was reduced with chronic HIV-1 
infection, although this trend was not statistically significant. 
DN T cell count was significantly reduced in these two group 
patients (HC vs. IR, p < 0.05; HC vs. INR, p < 0.0001). However, 
the ART effectively restored the level of DN T cells in IR group 
toward that found in HCs. In contrast, the frequency and count 
of DN T cells in INR group were only partially recovered after 
prolonged ART and could not match the levels observed in HCs 
or IRs (mean frequency: IR vs. INR, p < 0.05; mean count: HC 
vs. INR, p < 0.05; IR vs. INR, p < 0.01). Of note, the correlation 
analysis revealed that the DN T cell count positively correlated 
with the total CD4+ T cell count (Figures 2A,B) but not with viral 
load (Figures 2C,D).
inrs with Poor Dn T cell restoration after 
arT Display higher immune activation
The regulatory function of DN T cells is responsible for limiting 
the immune activation in HIV/SIV infection (5, 14). Therefore, 
we next determined the relationship between DN T cells and 
the level of immune activation in immune reconstitution. 
Co-expression of CD38 and HLA-DR on the surface of CD8+ 
T cells was used as a marker to evaluate the degree of immune 
activation. Compared to HCs, both IRs and INRs showed a sig-
nificant increased level of CD38+HLA-DR+CD8+ T cells during 
chronic HIV-1 infection (p < 0.0001) (Figure 3A). Although the 
long-term ART effectively reduced the overall immune activa-
tion among patients from both groups, the INR group displayed 
a higher level of CD38 and HLA-DR expression on CD8+ T cells 
in comparison to IRs (p < 0.05, Figure 3A). We next analyzed 
the relationship between immune activation and DN T cells in 
patients pre- or post-ART, respectively. We observed a significant 
negative correlation between the count of DN T cells and the level 
of CD38+HLA-DR+CD8+ T cells in patients after long-term ART 
(Figures 3B–E).
TgF-β1 Produced by Dn T cells 
Participates in the control of immune 
activation in hiV-1 Patients
To further elucidate the mechanism of DN T cells in the control 
of immune activation, PBMCs were stimulated for 5  h with 
PMA/ionomycin and assessed for immunosuppressive (IL-10 
and TGF-β1), Th1 (IFN-γ), Th2 (IL-4), Th17 (IL-17A), and 
5Lu et al. DN T Cells in HIV-1
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FigUre 3 | high level of immune activation is associated with incomplete recovery of double-negative (Dn) T cells after antiretroviral therapy (arT) 
in immunological non-responders. (a) Co-expression of CD38 and HLA-DR on the surface of CD8+ T cells was compared among three groups of subjects. 
Mann–Whitney U test was used for statistical analysis. Horizontal lines indicate mean values, and error bars represent mean ± SEM (*p < 0.05, ***p < 0.0001). 
Relationship analysis between the frequency of DN T cells and the level of immune activation pre-ART (b) and after ART (c) or the DN T cell count and the level of 
immune activation pre-ART (D) and after ART (e). The Spearman rank test was used for correlation analysis.
pro-inflammatory (TNF-α) cytokine producing by DN T cells. 
As shown in Figure 4A, in contrast to CD4+ T cells, the TGF-β1 
expressing DN T cells were detected in HIV-1 patients. In HCs, 
the expression of TGF-β1 by DN T cells was similar to that of 
unstimulated cells. The production of TGF-β1 in DN T cells was 
significantly unregulated after ART in IRs (p < 0.05); however, 
this increasing trend was not observed in INRs (Figure  4B). 
Furthermore, the level of TGF-β1-secreting DN T cells in IRs was 
much higher than that in INRs after ART (p < 0.05) (Figure 4B). 
Correlation analysis revealed that the proportion of TGF-β1 in 
DN T cells was negatively correlated with the level of immune 
activation after prolonged ART but not pre-ART in HIV-1 
patients (Figures  4C,D). However, cytokines of IL-4, IL-10, 
IL-17A, IFN-γ, and TNF-α from DN T cells did not have different 
significance between IRs and INRs after ART (data not shown). 
Therefore, we proposed that low TGF-β1-producing DN T cells 
may contribute to the incomplete reduction of immune activation 
in INRs despite ART.
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DiscUssiOn
This study was performed to investigate the role of DN T cells in 
immune reconstitution of HIV-1-infected individuals. In INRs, 
both the frequency and count of DN T cells were lower than in IRs 
after long-term ART. In addition, INRs displayed higher levels 
of immune activation than IRs. Mechanism study demonstrated 
that the secretion of TGF-β1 by DN T cells may be involved in the 
control of immune activation.
Several studies have demonstrated that a high level of DN 
T cells is associated with a non-pathogenic outcome in SIV host 
species (4, 5, 9). Consistent with the SIV study, we have previously 
observed a decrease in the number of DN T cells in CD4low HIV-1 
patients (13). The INRs typically have a higher risk of opportunis-
tic infections like AIDS or non-AIDS events than IRs and display 
increased morbidity and mortality (22). INRs and IRs have similar 
CD4+ T cell counts but the abnormal CD4+ T cell function may 
influence the outcome of antiviral immune responses (26). The 
DN T cells may compensate for the CD4+ T cells, therefore, poor 
restoration of these DN T cells in INRs (Figures 1B,C) may result 
in impaired immune responses during HIV-1 infection and thus 
accelerate the disease progression among these patients despite 
the fact that they have similar CD4+ T cell counts. Furthermore, 
the size and position of latent HIV-1 infection resulted in differ-
ent progression in HIV-1 patients (27–29). HIV-1 latent reservoir 
was identified in DN T cells (18), therefore, we proposed that 
FigUre 4 | secretion of TgF-β1 by double-negative (Dn) T cells contributes to the control of immune activation. Peripheral blood mononuclear cells were 
cultured in medium only (unstimulated) or in the presence of PMA/Ionomycin for 5 h. Cytokine release was measured in DN T cells and CD4+ T cells by ICS. (a) 
Gating strategy for TGF-β1 in DN T cells or CD4+ T cells. (b) TGF-β1 expression on DN T cells was compared between immunological responders (n = 12) and 
immunological non-responders (n = 10). Mann–Whitney U test was used for statistical analysis. Horizontal lines indicate mean values, and error bars represent 
mean ± SEM (*p < 0.05). Correlation between TGF-β1 expressing DN T cells and the level of immune activation pre-antiretroviral therapy (ART) (c) and after ART (D).
provirus harbored in DN T cells also contributes to the immune 
reconstitution failure in INRs.
The regulatory role of DN T cells has been demonstrated in 
HIV/SIV infection (5, 14). In SIV-infected sooty mangabeys, a 
lack of disease progression correlates with significant CD4+ T cell 
loss and is associated with DN T cells (5). These mangabeys 
exhibited low levels of immune activation, and the presence of 
DN T cells was believed to be responsible for this control (5). 
In primary HIV-1-infected individuals, elevated DN T cells were 
associated with the control of immune activation and lower viral 
load (14). The production of IL-10 and TGF-β1 by DN T cells has 
been suggested to participate to this outcome, which further sup-
ports the regulatory role of DN T cells (14). Consistent with these 
studies, we confirmed that INRs had higher immune activation 
than IRs after long-term ART, although ART resulted in an over-
all reduction in the immune activation as shown in Figure 3A. 
Moreover, we observed a negative correlation between DN T cells 
and the level of immune activation in HIV-1 patients after ART 
(Figure 3E). A high level of immune activation was previously 
proposed to contribute to the failure of immune reconstitution 
(23, 24). Further analysis revealed that the secretion of TGF-β1 by 
DN T cells was responsible for the control of immune activation 
after long-term ART (Figure 4). As we found that DN T cells were 
increased in IR patients, our results put forward the potential 
contribution of DN T cells in the process of immune reconstitu-
tion in HIV-1-infected patients.
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In conclusion, our study demonstrated that INRs have lower 
levels of DN T cells and exhibit higher immune activation than 
IRs after long-term ART. Because DN T cells have both CD4-
like and regulatory functions, the DN T cells in IRs may result 
in partial compensation of CD4+ T cell loss and in the control 
of immune activation, thereby improving the immunological 
response to ART in IRs.
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FigUre s1 | recovery of double-negative (Dn) T cells in hiV-infected 
patients after long-term antiretroviral therapy (arT). Healthy control 
(n = 18) and chronic HIV-infected patients (n = 36) were recruited in this study. 
Fresh blood of patients was collected before and after ART; peripheral blood 
mononuclear cells were isolated and stored at liquid nitrogen. Flow cytometry 
was performed as described in methods and materials. Frequency (a) and count 
(b) of DN T cells are compared among three groups. Mann–Whitney U test was 
used for statistical analysis. Horizontal lines indicate mean values, and error bars 
represent mean ± SEM (***p < 0.0001).
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